Trial updateRetina
An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)
Not yet recruiting. Phase 3. Registered enrolment: 605. Annexon, Inc.
Why it matters
Track this study through NCT07807969. No results are posted in this registry record.
The study at a glance
- Registry status
- Not yet recruiting
- Phase
- Phase 3
- Registered enrolment
- 605
- Results posted
- No
- Sponsor
- Annexon, Inc.
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.